American Academy of Pediatrics (AAP)
FDANonrulemakingFDA-2005-D-0460

Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act

RIN
Last modified
Jan 8, 2026
Comment window
closed 1107d ago
American Academy of Pediatrics (AAP) filings
2

Activity

American Academy of Pediatrics (AAP) filed 2 comments on this docket between Jul 21, 2023 and Jul 21, 2023. 2 other organizations filed here. The comment window closed 1107d ago.

What American Academy of Pediatrics (AAP) filed (2)

Jul 21, 2023· Comment from American Academy of Pediatrics· FDA-2005-D-0460-0023

Filed on regulations.gov — full text not in the inline record.

Jul 21, 2023· Comment from American Academy of Pediatrics· FDA-2005-D-0460-0022

Filed on regulations.gov — full text not in the inline record.

Abstract

Docket Status: OPEN

View on regulations.gov →